---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-22-032533"
form_type: "8-K"
ticker: "OPRX"
cik: "0001448431"
company_name: "OptimizeRx Corp"
filed_at: "2022-06-13T23:59:59+00:00"
generated_at: "2026-06-25T02:18:27.239429+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# OptimizeRx annual meeting elects directors, approves say-on-pay and auditor ratification

## Summary
- All six director nominees elected; Gus D. Halas received 4,000,363 votes withheld, highest among nominees.
- Advisory say-on-pay approved with 8,907,079 votes in favor vs 4,678,794 against.
- UHY LLP ratified as auditor for 2022 with 15,154,056 votes in favor, only 3,406 against.
- Record date April 14, 2022; 18,152,349 shares outstanding and entitled to vote.

## SEC filing metadata
- accession: 0001213900-22-032533
- form_type: 8-K
- ticker: OPRX
- cik: 0001448431
- company_name: OptimizeRx Corp
- filed_at: 2022-06-13T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1448431/000121390022032533/0001213900-22-032533-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1448431/000121390022032533/ea161459-8k_optimizerx.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-22-032533
- JSON: https://secwatch.observer/filing/0001213900-22-032533.json
- Plain text: https://secwatch.observer/filing/0001213900-22-032533.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.
